Inherited Respiratory System Disorders

Publish in



Please download to get full document.

View again

of 38
All materials on our website are shared by users. If you have any questions about copyright issues, please report us to resolve them. We are always happy to assist you.
Inherited Respiratory System Disorders. Cystic Fibrosis (CF). CF is the most common life-limiting autosomal recessive disorder in white population. CF is chronic , progressive, and frequently fatal genetic disease of the mucous glands .
Inherited Respiratory System DisordersCystic Fibrosis (CF)CF is the most common life-limiting autosomal recessive disorder in white population. CF is chronic, progressive, and frequently fatal genetic disease of the mucous glands.Affects the respiratory and digestive systems in children and young adults.An average person has a lifespan of 40 years with the right treatment.Cystic Fibrosis
  • Cystic Fibrosis is caused by a defective CFTR gene which codes for a Na+ and Cl- transporter found on the surface of epithelial cells of lungs and other organs.
  • CFTR - Cystic Fibrosis Transmembrane conduction Regulator
  • Cystic Fibrosis
  • Autosomal recessive
  • Gene cloned in 1989: “CFTR”
  • 1601 mutations in CFTR known to cause CF
  • An extensive amount of information is known about CFTR
  • Science, September 1989CFTR MutationEpithelial cell dysfunctionDisease manifestations Lungs Sinuses PancreasLiver Biliary duct Bones Vas deferensPathophysiology of CF?CF LungChloride does not get into airway; more sodium leaves; mucus is thickAirway Cross Sectional ViewMucus layerPericellular layerwith ciliaEpithelial cell layerKnowles & Boucher 2002;109:571Required Geometry for Effective Mucociliary ClearanceKnowles & Boucher 2002;109:571Consequences of CFTR Deficiency on Airway ClearanceKnowles & Boucher 2002;109:571CF Gene MutationIon Transport AbnormalitiesAltered AirwayEnvironmentInfectionInflammationTissueDamagePathophysiology of CF Lung DiseaseR. SimonPathophysiology of CFLung DiseaseCF Gene MutationRecurrent BronchitisBronchiectasisChronic RespiratoryFailureSource UndeterminedDeathR. SimonsClinical ManifestationsRespiratory Tract
  • Cough is the most constant symptom.
  • Wheezing
  • Recurrent chest infection
  • Cyanosis is a late sign
  • Atelactasis, hemoptysis, pneumothorax, and corpulmonale
  • Sinusitis, nasal polyps
  • Clinical Manifestations….Intestinal Tract
  • Meconium ileus 10-20%
  • Meconium plug syndrome (meconium ileus equivalent)…more than 85% of patients showed evidence of maldigestion from exocrine pancreatic insufficiency.
  • 3. Bile or acid reflux with oesophagitis4. Sub acute appendicitis5. Rectal prolapse6. Failure to thrive7. Fat-soluble vitamin deficiency manifestation.Clinical Manifestations…Biliary Tract
  • Biliary cirrhosis symptomatic in 2-3% .
  • Ascitis, Jaundice, hematemesis, esophageal varices
  • Neonatal hepatitis
  • Clinical Manifestations…
  • Diabetes Mellitus… 8% after the age of 10.
  • 95% of males are azoospermic because of failure of development of wolffian duct structure.
  • Secondary amenorrhea
  • Cervicitis
  • Hypochloremic alkalosis
  • Diagnostic criteria for CFAt least one of the following:1) One or more clinical manifestations of CF
  • Meconium ileus
  • Chronic bronchitis / bronchiectasis
  • Chronic infection of the paranasal sinuses
  • Pancreatic insufficiency
  • Salt loss syndromes
  • Male infertility due to congenital bilateral absence of the vas deferens
  • 2)History of CF in a siblingDiagnostic Criteria for CFAt least one of the following: 1)Elevated sweat chloride test
  • Identification of a mutation in each CFTR gene known to cause CF
  • The Sweat Test“Gold Standard” for testing over 40 years- painless - inexpensive - gives definite answersResults;
  • Cl- ≥ 60 mEq/L Positive
  • 40-60 mEq/L ?
  • G551DN1303KW1282X621+1G  TR553X1717-1G  AR1162XR117HΔ I5073849+10kbC  TR347PGenotyping for CF DiagnosisPopulation Frequency of Specific CFTR Mutations Causing CF
  • 1601 CFTR mutations known to cause CF
  • Only 25 mutations have a frequency > 0.1%
  • ΔF508G542X010203040506070Frequency, %CF Genetic Analysis Consortium Genotyping for CF Diagnosis
  • Current commercial screening tests
  • Look for presence of between 25 - 100 mutations
  • These will detect a CF allele only ~90% of time
  • For a group of patients with known CF, genotyping would be diagnostic in only ~81% of patients
  •  Screening for most common mutations is not as sensitive as sweat testing (98%) to diagnose classic CF
  • Genetic Diagnosis of CF
  • Tests becoming commercially available for detecting mutations more broadly
  • PCR used to amplify all exons and surrounding splice sites
  • Heteroduplex formation screening and/or sequencing
  • Analysis for large deletions and duplications
  • Cost ~ $2,500
  • CF: A Disease for aMultidisciplinary TeamThe Principles of management:
  • To Allow the child and his family, as far as possible, to enjoy a normal lifestyle.
  • To minimize the emotional problems that invariably develop.
  • To prevent, or at least retard as far as possible, progressive lung disease.
  • To achieve optimal nutrition and maintain normal growth
  • CF Treatment
  • PHYSIOTHERAPY and physical activity
  • Beta2 agonist
  • Corticosteroids for Bronchopulmopnaryaspergillosis
  • Hereditary Pulmonary Emphysema“alpha1 antitrypsin deficiency”
  • Emphysema - abnormal permanent enlargement of the airspace distal to the terminal bronchioles, accompanied by destruction of their walls and without obvious fibrosis.
  • Hereditary deficiency of α1-antitrypsin inhibitor accounts for about 2% of emphysema cases.
  • Alpha1 antitrypsin deficiency (AATD) is a autosomal recessive disorder characterized by a predisposition to emphysema and cirrhosis.
  • Alpha1 antitrypsin is a serin proteinase inhibitor that protect connective tissue of the lungs from the elastase released by leucocytes.Liver damage arises not from the deficiency of the protease inhibitor, but from pathological polymerization of the variant alpha1-antitrypsin before its secretion from hepatocytes.More than 75 alleles of the α1-antitrypsin inhibitor gene have been described. The three main phenotypes are ;MM (normal), MZ (heterozygous deficiency) and ZZ(homozygous deficiency). AATD is a Protein Folding Disease
  • Protein folding is the process by which an unfolded polypeptide chain folds in to a specific native and functional structure
  • Defective protein folding is an important mechanism underlying the pathogenesis of many diseases
  • Abnormal Folding and Polymerization of AAT
  • The most common and severe form of AAT deficiency is caused by e Z mutation, a single base substitution (Glu-342-lys) in the AAT gene.
  • This slows the rate of protein folding in the cell
  • Allowing the accumulation of an intermediate which polymerizes Impeeding its release
  • Leading to plasma deficiency
  • AAT PolymerPathogenesis of Lung Damage in AATDAATClinical CaseLung Related Clinical Manifestations
  • Emphysema
  • Presenting Symptoms:
  • Dyspnea (most common symptom)
  • Cough, phlegm production and wheezing
  • Bronchodilator responsiveness
  • Differences with patients w usual COPD
  • Earlier Age
  • Bullous changes prominent in lung bases
  • > 90 % of ZZ phenotype have lung bases involved
  • Limited to lung bases in 24 %Found exclusively in
  • Asthma and Bronchiectasis:
  • Relationship not proven
  • Diagnosis
  • Measure AAT level
  • Mutation analysis
  • Asthma
  • Asthma is a disorder that causes the airways of the lungs to swell and narrow, leading to wheezing, shortness of breath, chest tightness, and coughing.
  • Asthma is caused by inflammation in the airways.
  • Interest in finding a genetic susceptibility locus is based on the heritability that asthma shows.
  • Children with one asthmatic parent 3-6 times more likely to develop asthma than a child with two normal parents1.
  • Children with two asthmatic parents 10 times more likely to develop asthma than normal1.
  • Asthma: a complex phenotype«  Not a single disease entity but made up of various overlapping phenotypes … in people with different genetic predisposition & susceptible to different environmental triggers »OR«  A symptom (as fever): the clinical manifestation of several distinct diseases  Wenzel, Lancet, 20061 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X Y1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X YStrategies used to identify genes involved in asthma-related phenotypes No HypothesisGenome-wide screen approachLinkage studies ~ 400 genetic markers (microsatellites)Genome-wide association studies ~ 300 000 genetic markers (SNP)Fine mappingAssociationsGene discoveryHypothesis-drivenBiological studiesCandidate gene approach> 20 genome screens conducted to date
  • Populations:
  • Europeans+++, Australians, North-Americans, Chinese, Japanese
  • Regions most often replicated across populationsPhenotype linked to several regions: polygenic?One region linked to several phenotypes: one pleiotropy gene or several genes in the same region?1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 X YFEV1SPTQ21q21SPT 17q22IgE 12p13FEV16q14MultiRASTFEV1IgEAsthmaEOSSPTQSPTBRGENOME SCANOF 295EGEAFAMILIES for 8 asthma-related phenotypesBouzigon et al, Hum Mol Genet 2004Candidate gene approach> 500 association studies of asthma phenotypes(Ober & Hoffjan 2006)118 genes associated to asthma or atopy phenotypes 54 genes found in 2 to 5 independent studies15 genes found in 6 to 10 independent studies 10 genes found in > 10 independent studies IL4, IL13, CD14, IL4RA, ADRB2, HLA-DRB1, HLA-DQB1, TNF, FCER1B, (ADAM33)Pulmonary Fibrosis associated with known genetic causes
  • Neuofibromatosis
  • HermenskyPuldak Syndrome
  • Gaucher Disease
  • Niemann-Pick Disease
  • Tuberous sclerosis
  • Related Search
    We Need Your Support
    Thank you for visiting our website and your interest in our free products and services. We are nonprofit website to share and download documents. To the running of this website, we need your help to support us.

    Thanks to everyone for your continued support.

    No, Thanks